Seer, Inc.
General ticker "SEER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $112.7M (TTM average)
Seer, Inc. follows the US Stock Market performance with the rate: 11.5%.
Estimated limits based on current volatility of 1.0%: low 1.93$, high 1.97$
Factors to consider:
- Total employees count: 124 (-7.5%) as of 2025
- Top business risk factors: Net losses, Limited operating history, Market size, Commercialization challenges, IP protection failure
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.25$, 2.90$]
- 2026-12-31 to 2027-12-31 estimated range: [1.28$, 2.92$]
Financial Metrics affecting the SEER estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Investing cash flow per share per price, % of 58.68 > 2.08
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -19.91
- Positive: Shareholder equity ratio, % of 87.58 > 81.92
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SEER quotes
Long-term SEER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $16.66MM | $14.17MM | $16.58MM |
| Operating Expenses | $120.12MM | $114.27MM | $94.57MM |
| Operating Income | $-103.46MM | $-100.10MM | $-77.99MM |
| Non-Operating Income | $17.19MM | $13.60MM | $4.59MM |
| R&D Expense | $47.44MM | $50.59MM | $43.87MM |
| Income(Loss) | $-86.28MM | $-86.50MM | $-73.40MM |
| Taxes | $0.00MM | $0.10MM | $0.20MM |
| Net Income(Loss)* | $-86.28MM | $-86.60MM | $-73.60MM |
| Stockholders Equity | $396.90MM | $327.57MM | $259.31MM |
| Inventory | $4.49MM | $7.44MM | $7.79MM |
| Assets | $436.27MM | $366.60MM | $296.08MM |
| Operating Cash Flow | $-59.06MM | $-46.11MM | $-44.45MM |
| Capital expenditure | $7.31MM | $3.58MM | $1.80MM |
| Investing Cash Flow | $37.90MM | $65.86MM | $61.55MM |
| Financing Cash Flow | $0.45MM | $-11.49MM | $-10.57MM |
| Earnings Per Share** | $-1.35 | $-1.39 | $-1.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.